Logo image of ALFLO.PA

FLORENTAISE SA (ALFLO.PA) Stock Fundamental Analysis

EPA:ALFLO - Euronext Paris - Matif - FR001400GO75 - Common Stock - Currency: EUR

2.1  -0.01 (-0.47%)

Fundamental Rating

1

ALFLO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 60 industry peers in the Chemicals industry. ALFLO has a bad profitability rating. Also its financial health evaluation is rather negative. ALFLO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALFLO had negative earnings in the past year.
In the past year ALFLO has reported a negative cash flow from operations.
ALFLO had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALFLO reported negative operating cash flow in multiple years.
ALFLO.PA Yearly Net Income VS EBIT VS OCF VS FCFALFLO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.21%, ALFLO is doing worse than 61.40% of the companies in the same industry.
ALFLO has a Return On Equity of -0.68%. This is in the lower half of the industry: ALFLO underperforms 61.40% of its industry peers.
Industry RankSector Rank
ROA -0.21%
ROE -0.68%
ROIC N/A
ROA(3y)2.81%
ROA(5y)N/A
ROE(3y)13.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALFLO.PA Yearly ROA, ROE, ROICALFLO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of ALFLO has declined.
Looking at the Gross Margin, with a value of 41.22%, ALFLO is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
In the last couple of years the Gross Margin of ALFLO has declined.
ALFLO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.21%
PM growth 5YN/A
GM growth 3Y-3.87%
GM growth 5YN/A
ALFLO.PA Yearly Profit, Operating, Gross MarginsALFLO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

1

2. Health

2.1 Basic Checks

ALFLO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALFLO has about the same amount of shares outstanding.
Compared to 1 year ago, ALFLO has an improved debt to assets ratio.
ALFLO.PA Yearly Shares OutstandingALFLO.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALFLO.PA Yearly Total Debt VS Total AssetsALFLO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 0.94, we must say that ALFLO is in the distress zone and has some risk of bankruptcy.
ALFLO has a Altman-Z score of 0.94. This is in the lower half of the industry: ALFLO underperforms 75.44% of its industry peers.
A Debt/Equity ratio of 1.46 is on the high side and indicates that ALFLO has dependencies on debt financing.
ALFLO has a worse Debt to Equity ratio (1.46) than 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Altman-Z 0.94
ROIC/WACCN/A
WACC6.14%
ALFLO.PA Yearly LT Debt VS Equity VS FCFALFLO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

ALFLO has a Current Ratio of 1.35. This is a normal value and indicates that ALFLO is financially healthy and should not expect problems in meeting its short term obligations.
ALFLO has a Current ratio of 1.35. This is amonst the worse of the industry: ALFLO underperforms 80.70% of its industry peers.
ALFLO has a Quick Ratio of 1.35. This is a bad value and indicates that ALFLO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.52, ALFLO is not doing good in the industry: 94.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.52
ALFLO.PA Yearly Current Assets VS Current LiabilitesALFLO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

ALFLO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.41%.
The Revenue for ALFLO has decreased by -13.68% in the past year. This is quite bad
Measured over the past years, ALFLO shows a small growth in Revenue. The Revenue has been growing by 7.20% on average per year.
EPS 1Y (TTM)-79.41%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%-54.07%
Revenue 1Y (TTM)-13.68%
Revenue growth 3Y7.2%
Revenue growth 5YN/A
Sales Q2Q%31.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALFLO.PA Yearly Revenue VS EstimatesALFLO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 20M 40M 60M
ALFLO.PA Yearly EPS VS EstimatesALFLO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALFLO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALFLO.PA Price Earnings VS Forward Price EarningsALFLO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALFLO.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.83
ALFLO.PA Per share dataALFLO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALFLO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FLORENTAISE SA

EPA:ALFLO (2/4/2025, 7:00:00 PM)

2.1

-0.01 (-0.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners92.45%
Ins Owner ChangeN/A
Market Cap17.32M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP10.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB N/A
EV/EBITDA 10.83
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.87
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS7.06
BVpS3.7
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.21%
ROE -0.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.22%
FCFM N/A
ROA(3y)2.81%
ROA(5y)N/A
ROE(3y)13.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.21%
PM growth 5YN/A
GM growth 3Y-3.87%
GM growth 5YN/A
F-Score1
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Debt/EBITDA 7.93
Cap/Depr 128.95%
Cap/Sales 14.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.52
Altman-Z 0.94
F-Score1
WACC6.14%
ROIC/WACCN/A
Cap/Depr(3y)183.63%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.41%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%-54.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.68%
Revenue growth 3Y7.2%
Revenue growth 5YN/A
Sales Q2Q%31.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.41%
OCF growth 3YN/A
OCF growth 5YN/A